Clinical Trial Detail

NCT ID NCT02448251
Title Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors ACEA Biosciences, Inc.
Indications

lung non-small cell carcinoma

Therapies

Abivertinib

Age Groups: adult

No variant requirements are available.